We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » George A. Scangos to join Agilent Technologies board of directors

George A. Scangos to join Agilent Technologies board of directors

March 20, 2014
CenterWatch Staff

Agilent Technologies, a measurement and technology company focused on chemical analysis, life sciences, diagnostics, electronics and communications, has announced that George A. Scangos, Ph.D., CEO and director of Biogen Idec, has been appointed to Agilent’s board of directors and will join the board in September.

Previously, Scangos was president and CEO of Exelixis, a drug discovery and development company. He also previously was president of Bayer Biotechnology. Scangos was non-executive chairman of Anadys Pharmaceuticals, a biopharmaceutical company, from 2005 to 2010. He has been chair of the California Healthcare Institute and a member of the board of the Global Alliance for TB Drug Development.

Scangos replaces Dr. David Lawrence, who is retiring from the Agilent board after 13 years of service. 

Global News Awards & Advancement

Upcoming Events

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

  • China-360x240

    U.S. Tops List of Trial Startups With China Making Progress in Phase 1

  • Phoneapp-360x240

    Device Apps Present Unique Risks in Trials

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing